Healthtech firm launches world’s first consumer epigenetic testing kit with £1.12m investment

Jan 10, 2019 ·


Healthtech company Chronomics has raised seven-figure seed funding and launched the world’s first consumer epigenetic testing kit.

The company has secured over £1.12m funding to date, including significant investment from venture capital firm Anthemis and follow-on backing from SOSV.

Other investors in Chronomics include angel Laurence Garrett, senior partner at Highland Europe.

Chronomics is seeking to revolutionise attitudes towards health management. It offers an epigenetic saliva test that profiles specific lifestyle and environmental indicators and provides accurate insights into an individual’s health, including their biological age and metabolic status.

Read Complete Article

RT @LDNconnectory: We have a special announcement... Our website is live! Read all about our space, find out what's going on and meet our…

Real role models help bring real change to young people’s lives. Groups like @TheLionsSociety are doing exactly tha…

RT @JessRobertsOzUK: A (beautifully suited and booted) @AaronBirkby sharing Aussie @catalyst_au lessons from @LDNTechWeek #sclondon #scfemf…

Huawei sheds 100 Australian jobs in the face of 5G ban

There have been allegations of abuse at Epstein's sumptuous apartment near the Champs-Elysees in Paris.

More in London